GOLDMAN SACHS GROUP INC - EVOKE PHARMA INC ownership

EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 28 filers reported holding EVOKE PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of EVOKE PHARMA INC
ValueSharesWeighting
Q4 2020$54,000
-56.8%
20,978
-40.4%
0.00%
Q2 2020$125,00035,1740.00%
Other shareholders
EVOKE PHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 245,000$1,727,0000.80%
Knoll Capital Management, LLC 53,839$380,0000.11%
Financial Architects, Inc 4,300$30,0000.01%
C WorldWide Group Holding A/S 45,100$318,0000.01%
GEODE CAPITAL MANAGEMENT, LLC 15,864$111,0000.00%
BlackRock Investment Management, LLC 489$3,0000.00%
CITIGROUP INC 6$00.00%
MORGAN STANLEY 1,010$7,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 36,700$243,0000.00%
Tower Research Capital LLC (TRC) 200$1,0000.00%
View complete list of EVOKE PHARMA INC shareholders